Allianz Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Allianz Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-45,300	Closed	-$5.36M	–	2542
2021 Q1	$5.36M	Buy	45,300 +25,600	+130%	+$3.03M	0.01%	1037
2020 Q4	$2.33M	Buy	+19,700	New	+$2.29M	﹤0.01%	1269
2020 Q1	–	Sell	-22,500	Closed	-$2.62M	–	2861
2019 Q4	$2.62M	Buy	+22,500	New	+$2.61M	﹤0.01%	1757
2018 Q3	–	Sell	-18,066	Closed	-$1.79M	–	2803
2018 Q2	$1.79M	Hold	18,066	–	–	﹤0.01%	1991
2018 Q1	$1.46M	Hold	18,066	–	–	﹤0.01%	2061
2017 Q4	$1.42M	Sell	18,066 -1,806	-9%	-$150K	﹤0.01%	2128
2017 Q3	$1.83M	Hold	19,872	–	–	﹤0.01%	2039
2017 Q2	$2.23M	Sell	19,872 -18,551	-48%	-$2.07M	﹤0.01%	1943
2017 Q1	$3.85M	Buy	38,423 +2,149	+6%	+$230K	﹤0.01%	1736
2016 Q4	$3.9M	Buy	+36,274	New	+$4.24M	﹤0.01%	1736

Allianz Asset Management's CBPO Position: Q2 2021 in Review

Allianz Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 45,300 shares — an estimated $5.36M sold.

Allianz Asset Management first reported a position in CBPO in Q4 2016 and held it in 10 quarters. The position peaked at $5.36M in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Allianz Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Allianz Asset Management sold 45,300 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $5.36M.
Allianz Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q4 2016 and held it in 10 quarters.
Allianz Asset Management's China Biologic Products Holdings, Inc. position peaked at $5.36M in Q1 2021.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Allianz Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.